Avrido Pharmaceuticals Private Limited
About Avrido Pharmaceuticals Private Limited
Data last updated:
Avrido Pharmaceuticals Private Limited is a private limited company based in Noida, Uttar Pradesh, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 30 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24100UP2018PTC106622.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was formerly known as Sp Quick Expo Private Limited. It is led by directors including Naveen Kumar and Shashipal Yadav.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 25 G/F Sector 1, Noida, Uttar Pradesh, India – 201301.
As per the financials filed for FY 2022, the company reported a revenue of ₹36,750, a growth of 3% compared to the previous year. For the same year it recorded a net loss of ₹2,656 (net margin -7.2%) and EBITDA of ₹12,344 (EBITDA margin 33.6%).
Company details
CIN history
Avrido Pharmaceuticals has one previous CIN (Corporate Identification Number): U63030UP2018PTC106622. The current CIN is U24100UP2018PTC106622, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24100UP2018PTC106622 | Current |
| U63030UP2018PTC106622 | Previous |
Contact details
Avrido Pharmaceuticals Private Limited's registered office is in Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressB – 25 G/F Sector 1, Noida, Uttar Pradesh, India – 201301
- IndustryChemicals, Manufacturing, Basic Chemical
To see the full contact details of Avrido Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Avrido Pharmaceuticals Private Limited
FY 2025 filings availableAvrido Pharmaceuticals Private Limited reported revenue of ₹36,750 (up 3% YoY) for FY 2022.
Compounded Annual Growth Rate (CAGR)
Revenue rose 3% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ₹36,750 | |||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹12,344 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | -₹2,656 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 33.6% | |||
| Net Profit Margin | -7.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Avrido Pharmaceuticals Private Limited, buy the company report.
Board of directors of Avrido Pharmaceuticals Private Limited
Avrido Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Kumar Also directs: Edvision Abroadu Private Limited | Director | 30 Jul 2018 | 8 Years 3 Months | Current |
| Shashipal Yadav | Director | 30 Jul 2018 | 8 Years 3 Months | Current |
| Sushil Kumar Singh Also directs: Vivid Healthcare LLP | Director | 16 Aug 2022 | 4 Years 2 Months | Current |
Legal cases
No court or tribunal cases involving Avrido Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Avrido Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Avrido Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Avrido Pharmaceuticals Private Limited has 3 board changes on record since 2018: 3 appointments. The latest: Sushil Kumar Singh was appointed as Director on 16 Aug 2022.
Frequently asked questions
Avrido Pharmaceuticals is an active private limited company based in Noida, Uttar Pradesh, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 30 July 2018 (8+ years old) and is registered under CIN U24100UP2018PTC106622.
Avrido Pharmaceuticals has 3 current directors:
- Naveen Kumar - Director
- Shashipal Yadav - Director
- Sushil Kumar Singh - Director
The latest financial statements of Avrido Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The CIN (Corporate Identification Number) of Avrido Pharmaceuticals is U24100UP2018PTC106622. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Avrido Pharmaceuticals was incorporated on 30 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
Sushil Kumar Singh was appointed as Director on 16 Aug 2022. Naveen Kumar was appointed as Director on 30 Jul 2018. Shashipal Yadav was appointed as Director on 30 Jul 2018.
The registered office of Avrido Pharmaceuticals is at B – 25 GF Sector 1, Noida, Uttar Pradesh, India – 201301.
Avrido Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Yes. Avrido Pharmaceuticals was formerly known as Sp Quick Expo Private Limited.
Avrido Pharmaceuticals can be reached at its registered office: B – 25 GF Sector 1, Noida, Uttar Pradesh, India – 201301.